Pentavere, an early-stage digital health company, collaborates with six of the top ten largest pharmaceutical companies globally. Their breakthrough AI engine, DARWEN™, enables the conversion of complex clinical documentation into valuable insights, benefiting the entire healthcare ecosystem. By deploying Pentavere's AI technology, big pharma customers enhance their clinical workflows, make informed strategic decisions, and achieve significant cost savings. The company's clinical discovery platform accelerates the time-to-discovery of life-saving insights, leading to personalized and innovative health alternatives. Pentavere also addresses the issue of patients not receiving approved medications or interventions by using their AI engine to identify eligible patients, ultimately improving patient outcomes and driving therapy growth and penetration.